SoftMedx FY26 H1 profit rises 38.62% to HK$ 4.65 million; revenue falls 4.74% to HK$ 34.08 million

• SoftMedx Healthcare reported profit attributable to owners of HK$4.65 million in the six months ended June 30, up from HK$3.35 million a year earlier.
• Revenue slipped to HK$34.08 million from HK$35.77 million, while gross margin narrowed to 27.7% from 32.1%.
• Administrative expenses fell 20.8% to HK$3.61 million, reflecting cost controls and the absence of major litigation and corporate exercise costs.
• It recorded no fair-value loss on financial assets at FVTPL, after disposing of listed equity investments in 2025.
• The group ended June with HK$26.51 million in cash and no borrowings, and it did not recommend an interim dividend.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Softmedx Healthcare Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260810-12279129), on August 10, 2026, and is solely responsible for the information contained therein.